ThinPrep Pricing Level Improvement Drives Cytyc Q1 Revenues To $72.6 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Cytyc anticipates a second quarter launch for the ThinPrep automated imaging and review system, which is used with the company's cervical cancer screening test